CA Stock MarketDetailed Quotes

XPHY XPhyto Therapeutics Corp

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Nov 15 09:30 ET
0Market Cap0.00P/E (TTM)

XPhyto Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
45.25%-1.9M
74.67%-1.17M
-19.11%-12.16M
13.10%-1.63M
12.44%-2.47M
-20.06%-3.46M
-74.68%-4.6M
-176.53%-10.2M
-52.62%-1.87M
-130.76%-2.82M
Net income from continuing operations
67.51%-1.35M
67.20%-1.76M
-22.19%-20.64M
-203.10%-8.51M
61.79%-2.6M
-15.84%-4.16M
-45.54%-5.37M
-120.24%-16.89M
-28.13%-2.81M
-82.27%-6.8M
Operating gains losses
3,887.92%76.61K
227.01%45.18K
-103.93%-3.6K
253.25%26.94K
-95.59%3.11K
110.78%1.92K
-163.25%-35.57K
339.09%91.36K
-194.82%-17.58K
--70.53K
Depreciation and amortization
-63.95%74.4K
-71.88%59.13K
-8.17%823.22K
-4.46%201.79K
-3.16%204.77K
-17.50%206.37K
-5.98%210.29K
-5.16%896.47K
-14.73%211.22K
-17.26%211.46K
Asset impairment expenditure
----
----
87.77%3.68M
----
----
----
----
340.72%1.96M
--0
----
Remuneration paid in stock
-92.06%26.38K
-94.59%48.54K
26.31%3.28M
296.98%2.04M
-99.48%5.83K
345.86%332.15K
1.16%896.65K
46.22%2.59M
261.03%514K
-25.51%1.12M
Deferred tax
----
----
69.02%-110.74K
----
----
----
----
-694.05%-357.49K
-157.74%-116.04K
---163K
Other non cashItems
-202.47%-391.28K
-13.76%281.6K
-16.06%1.24M
99.25%343.02K
-54.42%188.46K
47.23%381.85K
-48.34%326.53K
105.42%1.48M
537.13%172.16K
-39.66%413.42K
Change In working capital
-47.97%-329.81K
125.41%160.53K
-1,692.80%-418.73K
308.64%704.37K
-171.10%-268.41K
-256.15%-222.89K
5.18%-631.8K
-85.37%26.29K
32.68%172.37K
72.91%377.52K
-Change in receivables
-88.88%9.91K
316.61%223.08K
-21.98%-214.53K
-172.36%-95.97K
-1,678.57%-104.66K
284.39%89.09K
61.40%-102.98K
-1,094.15%-175.87K
370.13%132.64K
117.88%6.63K
-Change in inventory
178.80%115.07K
---47.38K
---736.16K
---377.41K
---212.72K
---146.03K
--0
--0
----
----
-Change in prepaid assets
48.51%-69.84K
149.63%48.53K
683.60%75.63K
137.50%345.78K
-240.79%-36.74K
-517.90%-135.63K
54.96%-97.78K
87.62%-12.96K
2,591.34%145.59K
128.92%26.1K
-Change in payables and accrued expense
-1,169.44%-384.95K
85.22%-63.69K
112.12%456.33K
885.91%831.97K
-75.14%85.72K
-119.12%-30.32K
-136.31%-431.04K
-28.08%215.12K
-157.47%-105.86K
-0.44%344.79K
Cash from discontinued investing activities
Operating cash flow
45.25%-1.9M
74.67%-1.17M
-19.11%-12.16M
13.10%-1.63M
12.44%-2.47M
-20.06%-3.46M
-74.68%-4.6M
-176.53%-10.2M
-52.62%-1.87M
-149.54%-2.82M
Investing cash flow
Cash flow from continuing investing activities
0
0
-3,292.27%-5.31M
-4,553.83%-4.27M
-10,159.54%-654.68K
-481.14%-357.09K
-152.63%-24.62K
66.15%-156.47K
-988.97%-91.79K
101.52%6.51K
Net PPE purchase and sale
--0
--0
-189.09%-452.35K
85.72%-13.11K
-983.87%-57.52K
-481.14%-357.09K
-152.63%-24.62K
-59.22%-156.47K
-67.73%-91.79K
281.43%6.51K
Net business purchase and sale
----
----
---4.86M
---4.26M
----
----
----
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
-3,292.27%-5.31M
-4,553.83%-4.27M
-10,159.54%-654.68K
-481.14%-357.09K
-152.63%-24.62K
66.15%-156.47K
-988.97%-91.79K
101.52%6.51K
Financing cash flow
Cash flow from continuing financing activities
-62.02%702.87K
-70.20%1.67M
28.30%16.23M
48.79%6.24M
0.83%2.54M
7.96%1.85M
32.63%5.6M
508.48%12.65M
484.76%4.19M
1,104.44%2.52M
Net issuance payments of debt
-69.81%-263.13K
-6.48%-38.22K
-55.67%1.87M
-23.03%2.1M
84.93%-33.41K
-63.79%-154.95K
-101.98%-35.9K
4,130.74%4.23M
5,175.10%2.73M
-952.16%-221.62K
Net common stock issuance
--1.05M
-49.12%1.45M
--7.35M
--4.5M
--0
--0
--2.85M
--0
----
----
Proceeds from stock option exercised by employees
--0
-88.15%357K
-9.83%7.6M
--0
-6.09%2.58M
10.88%2.01M
25.30%3.01M
481.39%8.42M
90.29%1.47M
1,090.53%2.75M
Net other financing activities
---84K
56.16%-100K
---589.58K
---361.48K
--0
--0
---228.1K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-62.02%702.87K
-70.20%1.67M
28.30%16.23M
48.79%6.24M
0.83%2.54M
7.96%1.85M
32.63%5.6M
508.48%12.65M
484.76%4.19M
1,104.44%2.52M
Net cash flow
Beginning cash position
-48.07%1.85M
-47.70%1.35M
776.21%2.58M
185.92%1.02M
147.69%1.59M
89.78%3.56M
776.21%2.58M
-87.53%295.01K
-55.10%355.16K
-69.95%642.17K
Current changes in cash
39.43%-1.19M
-48.30%503.68K
-153.84%-1.23M
-84.80%338.7K
-101.77%-574.88K
-59.88%-1.97M
-38.28%974.22K
210.41%2.29M
546.63%2.23M
78.83%-284.92K
Effect of exchange rate changes
-668.01%-3.24K
-352.57%-6.04K
-174.13%-424
-261.22%-2.2K
90.71%-194
77.86%-422
-25.33%2.39K
-80.45%572
-53.38%1.36K
---2.09K
End cash Position
-58.96%652.72K
-48.07%1.85M
-47.70%1.35M
-47.70%1.35M
185.92%1.02M
147.69%1.59M
89.78%3.56M
776.21%2.58M
776.21%2.58M
-55.10%355.16K
Free cash from
50.37%-1.9M
74.81%-1.17M
-21.68%-12.61M
16.50%-1.64M
10.19%-2.52M
-29.68%-3.82M
-74.97%-4.62M
-171.98%-10.36M
-53.26%-1.96M
-144.76%-2.81M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 45.25%-1.9M74.67%-1.17M-19.11%-12.16M13.10%-1.63M12.44%-2.47M-20.06%-3.46M-74.68%-4.6M-176.53%-10.2M-52.62%-1.87M-130.76%-2.82M
Net income from continuing operations 67.51%-1.35M67.20%-1.76M-22.19%-20.64M-203.10%-8.51M61.79%-2.6M-15.84%-4.16M-45.54%-5.37M-120.24%-16.89M-28.13%-2.81M-82.27%-6.8M
Operating gains losses 3,887.92%76.61K227.01%45.18K-103.93%-3.6K253.25%26.94K-95.59%3.11K110.78%1.92K-163.25%-35.57K339.09%91.36K-194.82%-17.58K--70.53K
Depreciation and amortization -63.95%74.4K-71.88%59.13K-8.17%823.22K-4.46%201.79K-3.16%204.77K-17.50%206.37K-5.98%210.29K-5.16%896.47K-14.73%211.22K-17.26%211.46K
Asset impairment expenditure --------87.77%3.68M----------------340.72%1.96M--0----
Remuneration paid in stock -92.06%26.38K-94.59%48.54K26.31%3.28M296.98%2.04M-99.48%5.83K345.86%332.15K1.16%896.65K46.22%2.59M261.03%514K-25.51%1.12M
Deferred tax --------69.02%-110.74K-----------------694.05%-357.49K-157.74%-116.04K---163K
Other non cashItems -202.47%-391.28K-13.76%281.6K-16.06%1.24M99.25%343.02K-54.42%188.46K47.23%381.85K-48.34%326.53K105.42%1.48M537.13%172.16K-39.66%413.42K
Change In working capital -47.97%-329.81K125.41%160.53K-1,692.80%-418.73K308.64%704.37K-171.10%-268.41K-256.15%-222.89K5.18%-631.8K-85.37%26.29K32.68%172.37K72.91%377.52K
-Change in receivables -88.88%9.91K316.61%223.08K-21.98%-214.53K-172.36%-95.97K-1,678.57%-104.66K284.39%89.09K61.40%-102.98K-1,094.15%-175.87K370.13%132.64K117.88%6.63K
-Change in inventory 178.80%115.07K---47.38K---736.16K---377.41K---212.72K---146.03K--0--0--------
-Change in prepaid assets 48.51%-69.84K149.63%48.53K683.60%75.63K137.50%345.78K-240.79%-36.74K-517.90%-135.63K54.96%-97.78K87.62%-12.96K2,591.34%145.59K128.92%26.1K
-Change in payables and accrued expense -1,169.44%-384.95K85.22%-63.69K112.12%456.33K885.91%831.97K-75.14%85.72K-119.12%-30.32K-136.31%-431.04K-28.08%215.12K-157.47%-105.86K-0.44%344.79K
Cash from discontinued investing activities
Operating cash flow 45.25%-1.9M74.67%-1.17M-19.11%-12.16M13.10%-1.63M12.44%-2.47M-20.06%-3.46M-74.68%-4.6M-176.53%-10.2M-52.62%-1.87M-149.54%-2.82M
Investing cash flow
Cash flow from continuing investing activities 00-3,292.27%-5.31M-4,553.83%-4.27M-10,159.54%-654.68K-481.14%-357.09K-152.63%-24.62K66.15%-156.47K-988.97%-91.79K101.52%6.51K
Net PPE purchase and sale --0--0-189.09%-452.35K85.72%-13.11K-983.87%-57.52K-481.14%-357.09K-152.63%-24.62K-59.22%-156.47K-67.73%-91.79K281.43%6.51K
Net business purchase and sale -----------4.86M---4.26M--------------0--------
Cash from discontinued investing activities
Investing cash flow --0--0-3,292.27%-5.31M-4,553.83%-4.27M-10,159.54%-654.68K-481.14%-357.09K-152.63%-24.62K66.15%-156.47K-988.97%-91.79K101.52%6.51K
Financing cash flow
Cash flow from continuing financing activities -62.02%702.87K-70.20%1.67M28.30%16.23M48.79%6.24M0.83%2.54M7.96%1.85M32.63%5.6M508.48%12.65M484.76%4.19M1,104.44%2.52M
Net issuance payments of debt -69.81%-263.13K-6.48%-38.22K-55.67%1.87M-23.03%2.1M84.93%-33.41K-63.79%-154.95K-101.98%-35.9K4,130.74%4.23M5,175.10%2.73M-952.16%-221.62K
Net common stock issuance --1.05M-49.12%1.45M--7.35M--4.5M--0--0--2.85M--0--------
Proceeds from stock option exercised by employees --0-88.15%357K-9.83%7.6M--0-6.09%2.58M10.88%2.01M25.30%3.01M481.39%8.42M90.29%1.47M1,090.53%2.75M
Net other financing activities ---84K56.16%-100K---589.58K---361.48K--0--0---228.1K------------
Cash from discontinued financing activities
Financing cash flow -62.02%702.87K-70.20%1.67M28.30%16.23M48.79%6.24M0.83%2.54M7.96%1.85M32.63%5.6M508.48%12.65M484.76%4.19M1,104.44%2.52M
Net cash flow
Beginning cash position -48.07%1.85M-47.70%1.35M776.21%2.58M185.92%1.02M147.69%1.59M89.78%3.56M776.21%2.58M-87.53%295.01K-55.10%355.16K-69.95%642.17K
Current changes in cash 39.43%-1.19M-48.30%503.68K-153.84%-1.23M-84.80%338.7K-101.77%-574.88K-59.88%-1.97M-38.28%974.22K210.41%2.29M546.63%2.23M78.83%-284.92K
Effect of exchange rate changes -668.01%-3.24K-352.57%-6.04K-174.13%-424-261.22%-2.2K90.71%-19477.86%-422-25.33%2.39K-80.45%572-53.38%1.36K---2.09K
End cash Position -58.96%652.72K-48.07%1.85M-47.70%1.35M-47.70%1.35M185.92%1.02M147.69%1.59M89.78%3.56M776.21%2.58M776.21%2.58M-55.10%355.16K
Free cash from 50.37%-1.9M74.81%-1.17M-21.68%-12.61M16.50%-1.64M10.19%-2.52M-29.68%-3.82M-74.97%-4.62M-171.98%-10.36M-53.26%-1.96M-144.76%-2.81M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data